Literature DB >> 26795031

Proteomic Profile of Unstable Atheroma Plaque: Increased Neutrophil Defensin 1, Clusterin, and Apolipoprotein E Levels in Carotid Secretome.

Gemma Aragonès1, Teresa Auguet1,2, Esther Guiu-Jurado1, Alba Berlanga1, Marta Curriu1, Salomé Martinez3, Ajla Alibalic2, Carmen Aguilar1, Esteban Hernández4, María-Luisa Camara5, Núria Canela6, Pol Herrero6, Xavier Ruyra5, Vicente Martín-Paredero4, Cristóbal Richart1,2.   

Abstract

Because of the clinical significance of carotid atherosclerosis, the search for novel biomarkers has become a priority. The aim of the present study was to compare the protein secretion profile of the carotid atherosclerotic plaque (CAP, n = 12) and nonatherosclerotic mammary artery (MA, n = 10) secretomes. We used a nontargeted proteomic approach that incorporated tandem immunoaffinity depletion, iTRAQ labeling, and nanoflow liquid chromatography coupled to high-resolution mass spectrometry. In total, 162 proteins were quantified, of which 25 showed statistically significant differences in secretome levels between carotid atherosclerotic plaque and nondiseased mammary artery. We found increased levels of neutrophil defensin 1, apolipoprotein E, clusterin, and zinc-alpha-2-glycoprotein in CAP secretomes. Results were validated by ELISA assays. Also, differentially secreted proteins are involved in pathways such as focal adhesion and leukocyte transendothelial migration. In conclusion, this study provides a subset of identified proteins that are differently expressed in secretomes of clinical significance.

Entities:  

Keywords:  atheroma plaque; atherosclerosis; proteomic; secretome

Mesh:

Substances:

Year:  2016        PMID: 26795031     DOI: 10.1021/acs.jproteome.5b00936

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Extracellular Matrix Remodeling Factors as Markers of Carotid Artery Atherosclerosis.

Authors:  Agnieszka Sapa-Wojciechowska; Alina Rak-Pasikowska; Kornel Pormańczuk; Bartłomiej Czapla; Iwona Bil-Lula
Journal:  Cardiol Res Pract       Date:  2020-08-12       Impact factor: 1.866

2.  A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients.

Authors:  Javier Rodríguez-Carrio; Natalia Carrillo-López; Catalina Ulloa; Mariana Seijo; Minerva Rodríguez-García; Carmen Rodríguez-Suárez; Carmen Díaz-Corte; Jorge B Cannata-Andía; Ana Suárez; Adriana S Dusso
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

3.  Mass Spectrometry Imaging of atherosclerosis-affine Gadofluorine following Magnetic Resonance Imaging.

Authors:  Fabian Lohöfer; Rebecca Buchholz; Almut Glinzer; Katharina Huber; Helena Haas; Georgios Kaissis; Annette Feuchtinger; Michaela Aichler; Peter B Sporns; Carsten Höltke; Miriam Stölting; Franz Schilling; René M Botnar; Melanie A Kimm; Cornelius Faber; Axel K Walch; Alma Zernecke; Uwe Karst; Moritz Wildgruber
Journal:  Sci Rep       Date:  2020-01-09       Impact factor: 4.379

Review 4.  Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.

Authors:  Jennifer Wittwer; David Bradley
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

5.  Targeted metabolomic approach in men with carotid plaque.

Authors:  Teresa Auguet; Gemma Aragonès; Marina Colom; Carmen Aguilar; Vicente Martín-Paredero; Núria Canela; Xavier Ruyra; Cristóbal Richart
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

Review 6.  Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability.

Authors:  Núria Puig; Elena Jiménez-Xarrié; Pol Camps-Renom; Sonia Benitez
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

7.  Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture.

Authors:  Tomáš Vaisar; Jie H Hu; Sina A Gharib; David A Dichek; Nathan Airhart; Kate Fox; Jay Heinecke; Roberto F Nicosia; Ted Kohler; Zachary E Potter; Gabriel M Simon; Melissa M Dix; Benjamin F Cravatt
Journal:  Circ Res       Date:  2020-07-30       Impact factor: 23.213

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.